← All trials
NCT06830863
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 14, 2025
- Primary completion
- Feb 13, 2026
- Completion date
- Mar 13, 2026
- First posted
- Feb 17, 2025
- Last posted
- Feb 17, 2025
- Enrollment
- 32
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Azitra Inc.Lead sponsor
- Prosoft ClinicalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.